Global Immunohematology Market Growth, Forecast & Key Players

According to a newly published market research report by 24LifeSciences, global immunohematology market was valued at USD 1.38 billion in 2024 and is projected to reach USD 1.77 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025-2031.

Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15500/immunohematology-market

The Platelet Aggregation Devices Market is a specialized segment within the broader hemostasis, thrombosis, and in vitro diagnostics industry, focused on instruments used to assess platelet function, aggregation response, and antiplatelet therapy effects in clinical and research settings. These devices are used across hospital laboratories, hematology centers, cardiovascular care units, academic research institutions, and specialty diagnostic laboratories, with key applications including diagnosis of inherited and acquired platelet function disorders, monitoring response to antiplatelet agents, perioperative bleeding-risk assessment, and support for transfusion and thrombosis-related investigations. The market includes light transmission aggregometry systems, whole-blood impedance aggregometry platforms, and faster point-of-care platelet function testing technologies, each serving different workflow, throughput, and clinical decision needs. Recent trends highlight continued reliance on light transmission aggregometry as the reference-standard method in specialized laboratories, alongside growing interest in more streamlined and rapid whole-blood and point-of-care systems that support faster decision-making and simpler operation. Automation, digital workflow integration, assay standardization, and easier interpretation are becoming important themes as laboratories seek greater reproducibility and efficiency.